Aperiomics

United States
Greatwood, Texas, United States, 20166

Company profile

Aperiomics company profile

Aperiomics is the only company of its kind and scope in the world. We are revolutionizing the way that medical professionals around the world identify infections. Supported by the National Science Foundation, Aperiomics identifies every known bacteria, virus, fungus, and parasite through Deep Shotgun Metagenomic Sequencing, using our world renown database containing over 37,000 microbes. We help doctors and their patients identify the causes of infections that other tests cannot identify, thus streamlining the path to a positive clinical outcome. Many patients that we have helped were sick for years with no understanding of why. Patients and their physicians often contact Aperiomics after hearing about our life-changing success stories. Aperiomics was named Life Science Innovator of the Year in 2016 and International Start Up of the Year in 2018.

Business identity

Contact email
[email protected]
Phone number
703-229-0406
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2013-10-01

Headquarters

Postal code
20166
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
6
Total equity funding
$3.5M
Last funding
Convertible Note / $360,000 / 2020-12-14
Last equity funding
Series A / $1.2M
Investors
8
Lead investors
2
Founders
5
Articles
11

Founders and investors

Founders

Alvin ChenCrystal IcenhourEduardo Castro-NallarEvan JohnsonKeith Crandall

Lead investors

National Science FoundationVentureSouth

Investors

National Science FoundationPropel(X)Tamiami Angel FundsThe Launch PlaceVentureSouth